snk01
nkgen
['snk01', 'nkgen']
 the enrolled patients received weekly infusions of snk01 for 7 to 8 weeks (4 109 cells/dose [n = 6]; 6 109 cells/dose [n = 6]). since dose limiting toxicity was not observed, maximum tolerated dose of snk01 was determined to be 6 109 cells/dose. 